If you have worked in behavioral health long enough, the phrase “value-based care” starts to sound less like a strategy and more like a weather forecast. Everyone agrees it is coming. No one can say exactly when. And the people who have been preparing for it the longest are beginning to wonder if they packed the wrong clothes.

At the BHASe Summit, Nate Hartmann, COO of Symetria Recovery, moderated a panel that tried to cut through the fog. His guests were not consultants or policy analysts but operators: Audrey Whetsell, CEO of Medical Home Development Group; Siobhan Morse, Product Director for Addiction Services at Universal Health Services; and Eric Gremminger, CEO of ERPHealth and a person in long-term recovery himself. Between them, they have spent decades navigating the gap between what payers say they want and what providers can actually deliver.

Their message was neither optimistic nor pessimistic. It was practical. Value-based care is real, they said. It is also uneven, underdeveloped, and unforgiving of providers who chase contracts before building the infrastructure to support them.

The Ladder

Whetsell began by describing what she called the payment ladder, a progression that most providers will recognize even if they have not climbed it. At the bottom sits classic fee-for-service: you bill for what you do, and you get paid for what you bill. One rung up, fee-for-service with quality incentives adds a bonus for hitting certain metrics. Then comes shared savings, where a provider keeps a portion of the money it saves the payer, but only if there is money to save. Above that are bundled payments and two-sided risk arrangements, where providers can lose money if costs exceed expectations. At the top sits capitation, partial or full, where the provider receives a fixed payment per patient and bears responsibility for everything that happens within it.

None of this is theoretical. CMS has set a goal of having all Traditional Medicare beneficiaries in accountable care relationships by 2030. Commercial payers are experimenting with similar models. The direction is clear, even if the pace varies by market and by payer. Whetsell’s practical warning was that readiness is contract-specific and data-dependent. If you cannot prove the basics, she said, who you served, what you did, and what changed, then you should start with incentives and shared savings before chasing capitated dollars. The risk of moving too fast is that you sign a contract you cannot fulfill.

Three Audiences, Three Definitions of Success

Morse reframed the conversation around outcomes, but she resisted the idea that outcomes mean the same thing to everyone. Payers care about avoidable utilization and total cost of care. Families care about stability, about getting their loved one back, about knowing that the crisis is over. Clinicians care about whether the care plan worked and how to improve it next time.

All three perspectives are legitimate, she said. And if you want to succeed in value-based arrangements, you will need to speak all three languages. The payer wants to see that your intervention prevented an emergency room visit. The family wants to know that their son is filling his prescriptions and showing up to work. The clinician wants data that helps her adjust the treatment plan in real time. A provider that can only speak one of those languages will struggle to keep anyone satisfied for long.

Morse also pressed on infrastructure. Without what she called data liquidity, the ability to combine claims data, clinical data, patient-reported measures, and social determinants into a coherent picture, it becomes impossible to manage post-discharge events like medication refills and follow-up appointments. And those are precisely the metrics that drive value-based dollars.

Engagement Over Length of Stay

Gremminger, who brings both clinical experience and the credibility of someone who has been through treatment himself, offered a simpler heuristic. The best predictor of success in behavioral health, he said, is not length of stay. It is length of engagement.

His team has spent a decade collecting patient-reported outcome measures and studying what keeps people connected to care after they leave a facility. The answer, he argued, is not complicated. You surface risks in real time. You keep people engaged with accessible tools, multilingual options, even light gamification. You make it easy for someone to stay in the system rather than fall out of it. When you do that, you not only personalize care. You create the proof that payers require.

Gremminger also made a point that CFOs will appreciate. Preparing for value-based care does not mean waiting for value-based contracts. The same infrastructure that supports risk-bearing arrangements, strong utilization review packages tied to medical necessity, fewer avoidable denials, cleaner data on what is actually happening with patients, can yield immediate returns in today’s fee-for-service world. The investment is not speculative. It pays off now and pays off later.

What It Takes to Play

The panel offered a handful of concrete recommendations. Gremminger urged executives to know their numbers beyond finance. Average daily rate and margins matter, but so do engagement rates, patient satisfaction, readmissions, and care-continuity markers. Leadership teams need dashboards for both.

Morse emphasized building for whole-person care rather than siloed episodes. If you cannot provide the full continuum yourself, she said, contract for it. But either way, designate one accountable entity to coordinate and own the outcome. Fragmented care produces fragmented results.

Whetsell returned to sequencing. Use incentive deals and upside-only arrangements as training wheels while you mature your data, your workflows, and your partnerships. Do not leap to two-sided risk before you can measure what you are doing. And be transparent. Quote your outcome denominators and your limitations. Nothing erodes payer or public trust faster than glossy statistics drawn from twenty percent of your population.

Equity Is Not an Add-On

The panel returned repeatedly to equity, framing it not as a moral aspiration but as an operational requirement. If your tools do not work for people with low literacy, or in another language, or without reliable technology, you will measure the wrong population. You will miss the very events, emergency room visits, readmissions, that drive cost. Designing for access, they argued, is part of designing for value. A system that excludes vulnerable patients is a system that cannot accurately measure its own performance.

So Is It Real?

The consensus on stage was that value-based care is real, but unevenly distributed. Some markets are further along. Some payers are more aggressive. Some providers have been building the infrastructure for years, while others are still running on fee-for-service autopilot.

The advice was to treat value-based care less like a switch and more like a capability you grow. Start where your data can support you. Prove something narrow: timely follow-ups, medication adherence, reduced readmissions within thirty days. Earn trust. Then take on more risk.

Hartmann closed with what might be the most useful framing of all. At the core of every value-based arrangement, he said, is a moment between a vulnerable person and a prepared clinician. If your systems help that interaction happen earlier, be more personalized, and more coordinated, and if you can show that it did, the contracts will follow.

The weather, in other words, is not the point. The point is whether you are ready for it.